search
Back to results

Role of Pharyngeal High Resolution Manometry and Impedance in Swallow Function of Head and Neck Cancer Patients

Primary Purpose

Head and Neck Cancer, Dysphagia

Status
Withdrawn
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
pHRMi
Sponsored by
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Head and Neck Cancer

Eligibility Criteria

18 Years - 100 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Previously untreated head and neck cancer of any histology receiving radiation with curative oncologic intent regardless of the treatment modality.

    1. The radiation can be with or without prior surgery as part of the untreated HNC treatment plan.
    2. The radiation can include concurrent chemotherapy or without.
  2. Capable of providing informed consent.

Exclusion Criteria:

  1. Potential study subjects with contraindications for the HRMi procedure:

    1. Potential study subjects with altered mental status or obtundation.
    2. Potential study subjects who cannot understand or follow instructions.
    3. Potential study subjects with suspected or known obstruction precluding safe passage of the manometry catheter.
  2. Potential study subjects who are unwilling or unable to be adherent to longitudinal assessment and follow-up. This will include potential study subjects who have poor performance status at the time of study enrollment evaluation.
  3. Potential study subjects who have cognitive limitations / impairments that prevent a potential study subject's ability to provide self-reporting with the SSQ and the MDADI instrument.
  4. Potential study subjects who have motor skill limitations that prevent a potential study subject's ability to provide self-reporting with the SSQ and MDADI instrument.

Sites / Locations

  • SKCCC at Johns Hopkins (East Baltimore Campus)
  • Suburban Hospital

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

pHRMi in evaluation of swallowing function

Arm Description

Pharyngeal High Resolution Manometry and Impedance (pHRMi) evaluation of swallowing function at baseline, 3 months post radiation, then at 9 months

Outcomes

Primary Outcome Measures

Change in swallowing function as assessed by serial pHRMi
Use of serial pHRMi to identify biomechanical changes in the swallow function of HNC patients treated with radiotherapy.

Secondary Outcome Measures

Change in peak flow swallow measures
Analyze data to develop a classifier model for swallow function.

Full Information

First Posted
December 8, 2017
Last Updated
April 24, 2023
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
search

1. Study Identification

Unique Protocol Identification Number
NCT03372148
Brief Title
Role of Pharyngeal High Resolution Manometry and Impedance in Swallow Function of Head and Neck Cancer Patients
Official Title
Evaluating the Role of Pharyngeal High Resolution Manometry and Impedance (pHRMi) in the Longitudinal Evaluation of Swallow Function in Head and Neck Cancer Patients
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Withdrawn
Why Stopped
Study withdrawn by PI
Study Start Date
December 2023 (Anticipated)
Primary Completion Date
December 2027 (Anticipated)
Study Completion Date
December 2030 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Examining if the use of serial pHRMi to identify biomechanical changes in the swallow function of HNC patients treated with radiotherapy.
Detailed Description
Cancers located in the upper aerodigestive tract of the head and neck (HN) region present unique management challenges due to the crucial functions in this anatomic region along with its anatomic density. As such, cancers and the actual treatment can be functionally debilitating. Of these, the ability to effectively and safely transport a swallow bolus from the oral cavity to the esophagus is particularly important. This consideration has had a major influence regarding the optimal management for head and neck cancers as both oncologically effective and function-preserving therapies are desired. Accomplishing this therapeutic goal has been elusive due to a lack of tools that effectively and longitudinally evaluate swallow function over the course of a treatment and in follow-up. Standard of care approaches including modified barium swallow studies are typically used to characterize dysphagia once a clinical event has occurred such as pneumonia. As such, clinicians surprisingly lack a clear understanding of the natural history of head and neck cancer treatment - related swallow dysphagia (HNCTD) regardless of the treatment modality. Understanding which patient has HNCTD is especially important given increasing evidence that demonstrates that late secondary aspiration contributes to non-cancer related mortality in head and neck (HN) cancer patients. To address this problem, the investigator hypothesizes that the use of quantitative and validated approaches to measuring dysphagia will allow the investigators to better define the heterogeneity seen in patients with dysphagia to gain insights into its prevention including the mortality risk of aspiration pneumonia the investigators recently demonstrated 1. Work to date using the quantitative patient-reported outcome (PRO) instruments, the Sydney Swallow Questionnaire (SSQ) and the MD Anderson Dysphagia Inventory (MDADI) has demonstrated that a reproducible signature of swallow scores can define dysphagia in irradiated HNC patients. Pilot work to date has also demonstrated that pressure flow analysis (PFA) with artificial neural network (ANN) of pharyngeal high resolution manometry and impedance (pHRMi) studies in a heterogeneous cohort of HNC patients can significantly predict for the risk of clinical aspiration and for pneumonia. This pilot study will investigate the use of serial pHRMi to identify biomechanical changes in the swallow function of HNC patients treated with radiotherapy and secondarily evaluate how the PFA may add to the investigators current PRO-defined swallow signature.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Head and Neck Cancer, Dysphagia

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Pharyngeal High Resolution Manometry and Impedance (pHRMi) in the Longitudinal Evaluation of Swallow Function in Head and Neck Cancer Patients
Masking
None (Open Label)
Allocation
N/A
Enrollment
0 (Actual)

8. Arms, Groups, and Interventions

Arm Title
pHRMi in evaluation of swallowing function
Arm Type
Experimental
Arm Description
Pharyngeal High Resolution Manometry and Impedance (pHRMi) evaluation of swallowing function at baseline, 3 months post radiation, then at 9 months
Intervention Type
Diagnostic Test
Intervention Name(s)
pHRMi
Intervention Description
Pharyngeal High Resolution Manometry and Impedance swallowing function evaluation
Primary Outcome Measure Information:
Title
Change in swallowing function as assessed by serial pHRMi
Description
Use of serial pHRMi to identify biomechanical changes in the swallow function of HNC patients treated with radiotherapy.
Time Frame
Baseline, 3 months 9 months
Secondary Outcome Measure Information:
Title
Change in peak flow swallow measures
Description
Analyze data to develop a classifier model for swallow function.
Time Frame
9 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Previously untreated head and neck cancer of any histology receiving radiation with curative oncologic intent regardless of the treatment modality. The radiation can be with or without prior surgery as part of the untreated HNC treatment plan. The radiation can include concurrent chemotherapy or without. Capable of providing informed consent. Exclusion Criteria: Potential study subjects with contraindications for the HRMi procedure: Potential study subjects with altered mental status or obtundation. Potential study subjects who cannot understand or follow instructions. Potential study subjects with suspected or known obstruction precluding safe passage of the manometry catheter. Potential study subjects who are unwilling or unable to be adherent to longitudinal assessment and follow-up. This will include potential study subjects who have poor performance status at the time of study enrollment evaluation. Potential study subjects who have cognitive limitations / impairments that prevent a potential study subject's ability to provide self-reporting with the SSQ and the MDADI instrument. Potential study subjects who have motor skill limitations that prevent a potential study subject's ability to provide self-reporting with the SSQ and MDADI instrument.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Harry Quon, MD
Organizational Affiliation
SKCCC at Johns Hopkins (East Baltimore Campus)
Official's Role
Principal Investigator
Facility Information:
Facility Name
SKCCC at Johns Hopkins (East Baltimore Campus)
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21287
Country
United States
Facility Name
Suburban Hospital
City
Bethesda
State/Province
Maryland
ZIP/Postal Code
20817
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Role of Pharyngeal High Resolution Manometry and Impedance in Swallow Function of Head and Neck Cancer Patients

We'll reach out to this number within 24 hrs